Image for Voyager Clinical Trial

VOYAGER

A clinical trial of avapritinib versus regorafenib (Stivarga®) for people with advanced GIST that has progressed following first-line treatment with imatinib (Gleevec®) and one or two additional treatment regimens (third-line or fourth-line GIST).

Location Description

OHSU’s singular focus on improving health starts with Oregonians and has global impact. We are the only academic health center in Oregon, but we’re also nationally distinct as a university dedicated solely to advancing health sciences. 

Washington, District of Columbia Clinical Trial Location

OHSU – Knight Cancer Institute
3485 SW Bond Ave Center for Health and Healing, Building 2,
Portland, OR 97239